Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
BUSINESS OF BIOTECHNOLOGY
They're perfecting scientific developments that could cure the world's toughest diseases, improve food production, and even yield energy alternatives. This is the exciting world of biotechnology, where young companies fight to make innovative discoveries -- and to find new and innovative ways of funding those innovations.
Business of Biotechnology is part of Business Exchange, suggested by
Arlene Weintraub.
This topic contains
1,248 news
and
4,696 blog
items.
Read updated news, blogs, and resources about Business of Biotechnology. Find user-submitted articles and reactions on Business of Biotechnology from
like-minded professionals.
Blogs
Recent blog posts on this topic.
Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.
Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.
Copyright © thinkBiotech I will be at BIO 2013, representing BiotechBlog, the Journal of Commercial Biotechnology, and...
Swiss biotech Auris Medical has raised $50.6 million in a Series C round of financing to advance its two major...
Santaris Pharma has found another major pharma partner for its RNA drug platform. Bristol-Myers Squibb ($BMY) has...
A new analysis provides some explanation for why Johnson & Johnson ($JNJ) and other companies live at the top of...
Brace for more dour figures on venture investment in biotech. Despite some bright spots in life sciences venture...
Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.
Roche ($RHHBY) and the biotech startup Ascletis have joined forces to advance Roche's experimental drug danoprevir for...
As GlaxoSmithKline ($GSK) gears up for an advisory committee meeting on Breo, the British drug giant can expect to face...
Count Sanofi ($SNY) out of the wild chase to develop Alzheimer's drugs, at least while the best line of attack against...
Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.
Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.
Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.
Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.
Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.
Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.
Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.
Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.
Copyright © thinkBiotech This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology...
The list of biotechs going public grows longer. With public investors warming to biotech IPOs, Portola Pharmaceuticals...
There's Cambridge, and then there's Kendall Square, arguably the heart of all biotech activity in the Boston area.
Chimerix sped out of the IPO gate on Thursday. The Durham, NC-based drug developer's ($CMRX) stock soared on its first...
With pharma groups hunting for external innovation, an analysis shows a spike in early-stage biotech partnerships...
Top Sources: Business of Biotechnology
- Biotech Blog
- News
- Health Beat
- frontendofinnovation.blogspot.com
- Nature Biotechnology
- The Biotech Weblog
- policyinnovations.org
- Science Progress
- LinkedIn Answers: Technology
- World Pharma News / Published News
account